AXIM BIOTECHNOLOGIES, INC. — Form D

AXIM BIOTECHNOLOGIES, INC. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-21. The offering totals $600K, of which $600K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
George AnatassovDirectorNew York, NY
LeKhram ChangoerDirectorNijmegen, P7
Robert R CunninghamDirectorNew York, NY
John W Huemoeller IIDirectorNew York, NY
Blake N SchroederDirectorNew York, NY
Philip Van DammeDirectorNijmegen, P7
George AnatassovExecutive OfficerNew York, NY
LeKhram ChangoerExecutive OfficerNijmegen, P7
Robert W MalasekExecutive OfficerNew York, NY
Philip Van DammeExecutive OfficerNijmegen, P7
Robert MalasekExecutive OfficerDoylestown, PA
TIMOTHY R SCOTTDirectorSAN DIEGO, CA
MAURICO L BELLORADirectorSAN DIEGO, CA
ROBERT L CUNNINGHAMDirectorSAN DIEGO, CA
JOHN HUEMOELLER IIDirectorSAN DIEGO, CA
JOHN HUEMOELLER IIExecutive OfficerSAN DIEGO, CA
Dr. Philip A Van DammeDirectorNew York, NY
Dr. Philip A Van DammeExecutive OfficerNew York, NY
Dr. George AnastassovDirectorNew York, NY
Dr. George AnastassovExecutive OfficerNew York, NY
Lekhram A ChangoerDirectorNew York, NY
Lekhram A ChangoerExecutive OfficerNew York, NY

Other filings by this issuer (2)

FiledFormOfferingSold
2020-06-15D$5.0M$500K
2014-10-23D

More